Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial infections in patients hospitalized with COVID-19
Víctor Moreno‐Torres, Carmen de Mendoza, Sara de la Fuente, et al.
Internal and Emergency Medicine (2021) Vol. 17, Iss. 2, pp. 431-438
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Rapid Ferroelectric-Photoexcited Bacteria-Killing of Bi4Ti3O12/Ti3C2Tx Nanofiber Membranes
Zhiying Wang, Jianfang Li, Yuqian Qiao, et al.
Advanced Fiber Materials (2022) Vol. 5, Iss. 2, pp. 484-496
Open Access | Times Cited: 51
Antibiotics Use in COVID-19 Patients: A Systematic Literature Review
Guido Granata, Francesco Schiavone, Giuseppe Pipitone, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 7207-7207
Open Access | Times Cited: 32
Antibiotic Use and Bacterial Infection in COVID-19 Patients in the Second Phase of the SARS-CoV-2 Pandemic: A Scoping Review
Wenjuan Cong, Beth Stuart, Nour AIhusein, et al.
Antibiotics (2022) Vol. 11, Iss. 8, pp. 991-991
Open Access | Times Cited: 28
Corticosteroid Dosing Level, Incidence and Profile of Bacterial Blood Stream Infections in Hospitalized COVID-19 Patients
Ivan Papić, Petra Bistrović, Tomislav Čikara, et al.
Viruses (2024) Vol. 16, Iss. 1, pp. 86-86
Open Access | Times Cited: 7
A Retrospective Assessment of Sputum Samples and Antimicrobial Resistance in COVID-19 Patients
Talida Georgiana Cut, Adelina Mavrea, Alin Adrian Cumpănaş, et al.
Pathogens (2023) Vol. 12, Iss. 4, pp. 620-620
Open Access | Times Cited: 14
Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients
Alessio Molfino, Emanuela Anastasi, Eleonora Assanto, et al.
Internal and Emergency Medicine (2024) Vol. 19, Iss. 6, pp. 1557-1566
Open Access | Times Cited: 5
An Overview of the Impact of Bacterial Infections and the Associated Mortality Predictors in Patients with COVID-19 Admitted to a Tertiary Center from Eastern Europe
Amalia-Stefana Timpau, Radu-Ștefan Miftode, Irina‐Iuliana Costache, et al.
Antibiotics (2023) Vol. 12, Iss. 1, pp. 144-144
Open Access | Times Cited: 12
Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis
Javier Arranz-Herrero, Jesús Presa, Sergio Rius‐Rocabert, et al.
International Journal of Infectious Diseases (2023) Vol. 131, pp. 173-179
Open Access | Times Cited: 12
Bacterial Community- and Hospital-Acquired Pneumonia in Patients with Critical COVID-19—A Prospective Monocentric Cohort Study
Lenka Doubravská, Miroslava Htoutou Sedláková, Kateřina Fišerová, et al.
Antibiotics (2024) Vol. 13, Iss. 2, pp. 192-192
Open Access | Times Cited: 4
Clinical Telavancin Failure in Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
Kevin T Dao, Carlos D’Assumpcao, Rupam Sharma, et al.
Cureus (2025)
Open Access
COVID-19 in hospitalized solid organ transplant recipients in a nationwide registry study
Víctor Moreno‐Torres, María Martínez‐Urbistondo, Jorge Calderón‐Parra, et al.
International Journal of Infectious Diseases (2023) Vol. 134, pp. 154-159
Open Access | Times Cited: 9
Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
María Martínez‐Urbistondo, Ángela Gutiérrez‐Rojas, Ane Andrés, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3595-3595
Open Access | Times Cited: 23
Advances in attractive therapeutic approach for macrophage activation syndrome in COVID-19
Shunyao Chen, Cong Zhang, Deng Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
A Retrospective Analysis of the Bacterial Infections, Antibiotic Use, and Mortality Predictors of COVID-19 Patients
I Wayan Suranadi, I Made Agus Kresna Sucandra, Ni Nengah Dwi Fatmawati, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 3591-3603
Open Access | Times Cited: 11
Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania
Alexandru Noris Novacescu, Bettina Buzzi, Ovidiu Horea Bedreag, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 7001-7014
Open Access | Times Cited: 11
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India
Lipin Lukose, Gursimran Kaur, M. Mohammed Asif, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 5, pp. 333-341
Open Access | Times Cited: 2
Development and validation of machine learning-based models for predicting healthcare-associated bacterial/fungal infections among COVID-19 inpatients: a retrospective cohort study
Min Wang, Wenjuan Li, Hui Wang, et al.
Antimicrobial Resistance and Infection Control (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
The Evolving Challenge of Appropriate Antibiotics Use in Hospitalized COVID-19 Patients: A Systematic Literature Review
Guido Granata, Stefania Cicalini
Antibiotics (2024) Vol. 13, Iss. 6, pp. 545-545
Open Access | Times Cited: 2
A Review of Antibiotic Efficacy in COVID-19 Control
Hamidreza Hekmat, Aziz Rasooli, Zeinab Siami, et al.
Journal of Immunology Research (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 5
Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort
Rodrigo San‐Cristobal, Roberto Martín‐Hernández, Omar Ramos-López, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3327-3327
Open Access | Times Cited: 8
The impact of COVID-19 pandemic on healthcare associated infections: A teaching hospital experience
Haneen M. Obeidat, Ziad Elnasser, Zouhair Amarin, et al.
Medicine (2023) Vol. 102, Iss. 15, pp. e33488-e33488
Open Access | Times Cited: 4
COVID-19 and the Interplay With Antibacterial Drug Resistance
Laxmi Kant Bhardwaj, Prangya Rath, Shubhansh Bajpai, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 246-273
Closed Access | Times Cited: 1
Test the effectiveness of some medications and vitamin D3 used against COVID-19 on Gram-positive and Gram-negative bacteria isolated from people infected with the Coronavirus
Amal F. AL-Gorani, Hanan Saadon, Ahmed. K. Ajeel, et al.
University of Thi-Qar Journal of Science (2024) Vol. 11, Iss. 1, pp. 102-107
Open Access | Times Cited: 1
Pre-Existing Lymphopenia Increases the Risk of Hospitalization and Death after SARS-CoV-2 Infection
Riccardo Garbo, Francesca Valent, Gian Luigi Gigli, et al.
Infectious Disease Reports (2022) Vol. 14, Iss. 1, pp. 20-25
Open Access | Times Cited: 7
Identification of risk factors and development of a predictive model for bloodstream infection in intensive care unit COVID-19 patients
Daria Strelkova, Svetlana Rachina, L Fedina, et al.
Journal of Hospital Infection (2023) Vol. 139, pp. 150-157
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top